mrs LAUREN SEMENIUK

HR 2584/S 1361 Preventive Health Savings Act (issues related to CBO scoring of preventive health services); "Buy American" procurement issues in PL 116-136 Coronavirus Aid, Relief, and Economic Security (CARES) Act; CMS Authority to Provide Coverage for Anti-Obesity Agents Under Part D in FY21 Labor-HHS-Education Appropriations; HR 8337 Continuing Appropriations Act, 2021 and Other Extensions Act (issues related to expiring health programs)

Medication affordability and access; general diabetes prevention; S 1948/HR 3709 Chronic Disease Management Act and general issues related to High Deductible Health Plan pre-deductible coverage of treatments and services for chronic diseases; implementation of P.L. 115-80 (H.R. 309/S. 920) Clinical Care Commission Act; S 2199/H.R. 4906 Insulin Price Reduction Act; H.R. 3 Elijah Cummings Lower Drug Costs Now Act; S. 1895 Lower Health Care Costs Act; H.R. 19/S 3129 Lower Costs, More Cures Act

H.R. 1530/S. 595 Treat and Reduce Obesity Act and obesity treatment in COVID-19 relief; H.R. 1840/S. 814 Expanding Access to DSMT Act (Diabetes Self-Management Training); Medicare Diabetes Prevention Program; issues related to podiatric services; issues related to diabetic vision loss and blindness prevention; CMS coverage of diabetes technologies/services; virtual Medicare Diabetes Prevention Program (DPP) diabetes self-management education; issues related to Medicare Part D; issues related to International Price Indexing (IPI)/reference pricing in Medicare; H.R. 107 related to maximum Medicaid rebates; Medicare Part D Rebate Rule; 6 Protected Classes in Medicare Part D; S.2543 Prescription Drug Pricing Reduction Act

Issues related to lobbying disclosure and political participation for US affiliates in H.R. 1 For the People Act.

Issues related to implementation of P.L. 115-97 Tax Cuts and Jobs Act of 2017

HR 2584/S 1361 Preventive Health Savings Act (issues related to CBO scoring of preventive health services)

Medication affordability and access; general diabetes prevention; S 1948/HR 3709 Chronic Disease Management Act and general issues related to High Deductible Health Plan pre-deductible coverage of treatments and services for chronic diseases; implementation of P.L. 115-80 (H.R. 309/S. 920) Clinical Care Commission Act

TRICARE pharmacy provisions in HR 2500 FY2020 National Defense Authorization Act (NDAA)

Issues related to CBO scoring of preventive health services

H.R. 1530/S. 595 Treat and Reduce Obesity Act; H.R. 1840/S. 814 Expanding Access to DSMT Act (Diabetes Self-Management Training); Medicare Diabetes Prevention Program; issues related to podiatric services; issues related to diabetic vision loss and blindness prevention; CMS coverage of diabetes technologies/services; virtual Medicare Diabetes Prevention Program (DPP) diabetes self-management education; issues related to Medicare Part D; issues related to International Price Indexing (IPI)/reference pricing in Medicare; H.R. 107 related to maximum Medicaid rebates; Medicare Part D Rebate Rule; 6 Protected Classes in Medicare Part D

Insulin pen access

Medicare Diabetes Prevention Program; diabetes self-management education; H.R. 3124/S. 1299/Preventing Diabetes in Medicare Act; H.R. 1953/S. 830 Treat and Reduce Obesity Act; Issues related to Medicare Part D including coverage gap ("donut hole") access and averting catastrophic coverage Out of Pocket (OOP) "cliff"; Protecting Seniors Access to Medicare Act of 2017 and S. 251 Protecting Medicare from Executive Action Act of 2017 (IPAB Repeal); H.R. 1542 Helping Ensure Life- and Limb-Saving Access to Podiatric Physicians Act (HELLPP Act); H.R. 3921 HEALTHY KIDS Act (CHIP Reauthorization; H.R. 5768/S. 3366 Expanding Access to Diabetes Self-Management Training (DSMT)Act of 2018; HR 6639 Diabetic Vision Loss and Blindness Prevention Act of 2018 and related Medicare Physician Fee Schedule diabetes issues; CMS coverage of diabetes technologies/services; virtual Medicare Diabetes Prevention Program (DPP)

Issues related to lobbying disclosure for US affiliates in H.R.4170/S. 2039 Disclosing Foreign Influence Act and S. 2482 Foreign Agents Registration Amendments Act of 2018, and issues related to inbound investment in H.R. 4311/S.2098 Foreign Investment Risk Review Modernization Act of 2017 (CFIUS reform).

2018 Congressional trade agenda generally

General diabetes prevention; medication affordability and access; implementation of P.L. 115-80 (H.R. 309/S. 920) Clinical Care Commission Act; H.R. 1628 American Health Care Act (AHCA) and Better Care Reconciliation Act of 2017; World Hemophilia Day; H.R.4978/S. 2410 Chronic Disease Management Act of 2018; Draft legislation related to "Medical Shared Savings for Citizens and Communities to Power Economic Development, Lower Health Care Costs and Expanded Insurance Coverage" i.e. Community Health Savings Accounts (HSAs); Growth Awareness Week 2018

Implementation of P.L. 115-97 (H.R. 1 Tax Cuts and Jobs Act).

Medicare Diabetes Prevention Program; diabetes self-management education; H.R. 3124/S. 1299/Preventing Diabetes in Medicare Act; H.R. 1953/S. 830 Treat and Reduce Obesity Act; Issues related to Medicare Part D including coverage gap ("donut hole") access and averting catastrophic coverage Out of Pocket (OOP) "cliff"; Protecting Seniors Access to Medicare Act of 2017 and S. 251 Protecting Medicare from Executive Action Act of 2017 (IPAB Repeal); H.R. 1542 Helping Ensure Life- and Limb-Saving Access to Podiatric Physicians Act (HELLPP Act); H.R. 3921 HEALTHY KIDS Act (CHIP Reauthorization; H.R. 5768 Expanding Access to Diabetes Self-Management Training (DSMT)Act of 2018; HR 6639 Diabetic Vision Loss and Blindness Prevention Act of 2018 and related Medicare Physician Fee Schedule diabetes issues; CMS coverage of diabetes technologies/services; virtual Medicare Diabetes Prevention Program (DPP)

H.R. 2953/S. 2164 Preventative Health Savings Act (CBO scoring of preventive health); National Diabetes Prevention Program and other CDC diabetes prevention activities in P.L. 115-96 (CR of FY18 Labor, Health and Human Services, and Education Appropriations)and FY19 Labor, Health and Human Services, and Education Appropriations.

Issues related to P.L. 115-52 (H.R. 2430/S. 934) FDA Reauthorization Act of 2017 (Prescription Drug User Fee Act VI); H.R. 1245/S. 469 Affordable and Safe Prescription Drug Importation Act; H.R. 1776/S.771 Improving Access To Affordable Prescription Drugs Act; H.R. 4710, the 340B Protecting Access for the Underserved and Safety-Net Entities Act (340 PAUSE Act)and other issues related to 340B program

Insulin pen access

2018 Congressional trade agenda generally

Implementation of P.L. 115-97 (H.R. 1 Tax Cuts and Jobs Act).

H.R. 2953/S. 2164 Preventative Health Savings Act (CBO scoring of preventive health); National Diabetes Prevention Program and other CDC diabetes prevention activities in P.L. 115-96 (CR of FY18 Labor, Health and Human Services, and Education Appropriations)and FY19 Labor, Health and Human Services, and Education Appropriations.

Issues related to lobbying disclosure for US affiliates in H.R.4170/S. 2039 Disclosing Foreign Influence Act and S. 2482 Foreign Agents Registration Amendments Act of 2018, and issues related to inbound investment in H.R. 4311/S.2098 Foreign Investment Risk Review Modernization Act of 2017 (CFIUS reform).

General diabetes prevention; medication affordability and access; implementation of P.L. 115-80 (H.R. 309/S. 920) Clinical Care Commission Act; H.R. 1628 American Health Care Act (AHCA) and Better Care Reconciliation Act of 2017; World Hemophilia Day; H.R.4978/S. 2410 Chronic Disease Management Act of 2018; Draft legislation related to "Medical Shared Savings for Citizens and Communities to Power Economic Development, Lower Health Care Costs and Expanded Insurance Coverage" i.e. Community Health Savings Accounts (HSAs)

Issues related to P.L. 115-52 (H.R. 2430/S. 934) FDA Reauthorization Act of 2017 (Prescription Drug User Fee Act VI); H.R. 1245/S. 469 Affordable and Safe Prescription Drug Importation Act; H.R. 1776/S.771 Improving Access To Affordable Prescription Drugs Act; H.R. 4710, the 340B Protecting Access for the Underserved and Safety-Net Entities Act (340 PAUSE Act)and other issues related to 340B program

Medicare Diabetes Prevention Program; diabetes self-management education; H.R. 3124/S. 1299/Preventing Diabetes in Medicare Act; H.R. 1953/S. 830 Treat and Reduce Obesity Act; Issues related to Medicare Part D included in H.R. 1892 (P.L. 115-123)Bipartisan Budget Act and H.R. 1625 (P.L. 115-141) Consolidated Appropriations Act; H.R. 849/S. 260; Protecting Seniors Access to Medicare Act of 2017 and S. 251 Protecting Medicare from Executive Action Act of 2017 (IPAB Repeal); H.R. 1542 Helping Ensure Life- and Limb-Saving Access to Podiatric Physicians Act (HELLPP Act); H.R. 3921 HEALTHY KIDS Act (CHIP Reauthorization; H.R. 5768 Expanding Access to Diabetes Self-Management Training (DSMT)Act of 2018

Issues related to P.L. 115-52 (H.R. 2430/S. 934) FDA Reauthorization Act of 2017 (Prescription Drug User Fee Act VI); H.R. 1245/S. 469 Affordable and Safe Prescription Drug Importation Act; H.R. 1776/S.771 Improving Access To Affordable Prescription Drugs Act; H.R. 4710, the 340B Protecting Access for the Underserved and Safety-Net Entities Act (340 PAUSE Act)and other issues related to 340B program

TRICARE pharmacy benefit in National Defense Authorization Act (NDAA).

Issues related to lobbying disclosure for US affiliates in H.R.4170/S. 2039 Disclosing Foreign Influence Act and S. 2482 Foreign Agents Registration Amendments Act of 2018, and issues related to inbound investment in H.R. 4311/S.2098 Foreign Investment Risk Review Modernization Act of 2017 (CFIUS reform).

General diabetes prevention; medication affordability and access; implementation of P.L. 115-80 (H.R. 309/S. 920) Clinical Care Commission Act; H.R. 1628 American Health Care Act (AHCA) and Better Care Reconciliation Act of 2017; World Hemophilia Day; H.R.4978/S. 2410 Chronic Disease Management Act of 2018.

2018 Congressional trade agenda generally

Implementation of P.L. 115-97 (H.R. 1 Tax Cuts and Jobs Act).

General diabetes prevention; P.L. 115-80 (H.R. 309/S. 920) Clinical Care Commission Act; H.R. 1628 American Health Care Act (AHCA) and Better Care Reconciliation Act of 2017; World Hemophilia Day; Growth Awareness Week; H. Res. 142 and S. Res. 63/S. Res. 325 (A resolution) expressing support for designation of the week of October 29 through November 4, 2017, as "National Obesity Care Week".

Medicare Diabetes Prevention Program; diabetes self-management education; H.R. 3124/S. 1299/Preventing Diabetes in Medicare Act; H.R. 1953/S. 830 Treat and Reduce Obesity Act; Issues related to Medicare Part D; H.R. 849/S. 260 Protecting Seniors Access to Medicare Act of 2017 and S. 251 Protecting Medicare from Executive Action Act of 2017 (IPAB Repeal); H.R. 1542 Helping Ensure Life- and Limb-Saving Access to Podiatric Physicians Act (HELLPP Act); H.R. 3921 HEALTHY KIDS Act (CHIP Reauthorization)

P.L. 115-97 (H.R. 1 Tax Cuts and Jobs Act)including Orphan Drug Tax Credit (ODTC), Base Erosion Anti-Abuse Tax (BEAT), earlier border adjustment tax proposals, and interest deductibility provisions.

TRICARE pharmacy benefit in P.L. 115-91 H.R. 2810 FY18 National Defense Authorization Act (NDAA).

Issues related to H.R. 2430/S. 934 FDA Reauthorization Act of 2017 (Prescription Drug User Fee Act VI); H.R. 1245/S. 469 Affordable and Safe Prescription Drug Importation Act; H.R. 1776/S.771 Improving Access To Affordable Prescription Drugs Act; issues related to 340B program

TRICARE pharmacy benefit in H.R. 2810 FY18 National Defense Authorization Act (NDAA).

Medicare Diabetes Prevention Program; diabetes self-management education; H.R. 3124/S. 1299/Preventing Diabetes in Medicare Act; H.R. 1953/S. 830 Treat and Reduce Obesity Act; Issues related to Medicare Part D; H.R. 849/S. 260 Protecting Seniors Access to Medicare Act of 2017 and S. 251 Protecting Medicare from Executive Action Act of 2017 (IPAB Repeal); H.R. 1542 Helping Ensure Life- and Limb-Saving Access to Podiatric Physicians Act (HELLPP Act); H.R. 3921 HEALTHY KIDS Act (CHIP Reauthorization)

Comprehensive corporate tax reform, including border adjustment tax and interest deductibility

TRICARE pharmacy benefit in H.R. 2810 FY18 National Defense Authorization Act (NDAA).

2017 Congressional trade agenda generally

General diabetes prevention; H.R. 309/S. 920 Clinical Care Commission Act; H.R. 1628 American Health Care Act (AHCA) and Better Care Reconciliation Act of 2017; World Hemophilia Day

Issues related to diabetes, obesity, hemophilia, and growth deficiency.

Issues related to diabetes, obesity, hemophilia, and growth deficiency.

Issues related to diabetes, obesity, hemophilia, and growth deficiency.

Issues related to diabetes, obesity, hemophilia, and growth deficiency.

Issues related to scoring of preventive health; National Diabetes Prevention Program

General diabetes prevention; H.R. 309 Clinical Care Commission Act; H.R. 1628 American Health Care Act (AHCA); H.R. 1776 / S.771 Improving Access To Affordable Prescription Drugs Act; World Hemophilia Day

2017 Congressional trade agenda generally

Issues related to Prescription Drug User Fee Act VI; issues related to 340B program; H.R. 1245/S. 469 Affordable and Safe Prescription Drug Importation Act

Issues related to National Diabetes Prevention Program in FY17 Labor/HHS/Education Appropriations, P.L. 114-113 FY16 Consolidated Appropriations, and P.L. 113-235 FY15 Consolidated and Continuing Appropriations; Issues related to Medicare Part D, FDA, patents, and federal procurement in S.Con.Res.11 FY16 Senate Budget Resolution and H.Con.Res.27 House Budget Resolution; H.R. 3660 and S.3126 Preventive Health Savings Act

Protecting Americans from Tax Hikes Act of 2015(PATH) provision of P.L. 114-113 FY16 Consolidated Appropriations; H.R. 880 R&D tax credit; corporate tax inversion generally and in amendments to S.Con.Res.11 FY16 Senate Budget Resolution and S. 1376 FY16 National Defense Authorization Act; interest deductibility IRC 163(j); Treasury proposed debt and equity regulations (Sec. 385)

National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), AHRQ and USPSTF diabetes screening standards; diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1192 and S. 586 National Diabetes Clinical Care Commission Act of 2015; P.L. 114-10, Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) for Special Diabetes Program, CHIP, and childhood obesity; S. 84 and H.R. 3658 Gestational Diabetes Act of 2015; H.R. 1190 and S. 141 Protecting Seniors' Access to Medicare Act of 2015 (IPAB repeal); H.R. 2651 Eliminating Disparities in Diabetes Prevention, Access, and Care Act of 2015 (EDDPAC); cost of diabetes generally; S. 320 and H.R. 744 Medical Innovation Act of 2015; S. 2023 and H.R. 3513 Prescription Drug Affordability Act of 2015; H.R. 3742, Access to Marketplace Insurance Act and general allowance for certain third party payments of cost sharing; Congressional recognition of World Hemophilia Day and Growth Awareness Week.

Issues related to TRICARE pharmacy benefit in HR4909 and S 2943 FY17 National Defense Authorization Act.

P.L. 114-26 Bipartisan Congressional Trade Priorities and Accountability Act of 2015; EU/US Transatlantic Trade and Investment Partnership (TTIP) (intellectual property, regulatory harmonization)

H.R. 9 Innovation Act and and S. 1137 PATENT Act (patent litigation and assertion); S.1890 and H.R.3326 Defend Trade Secrets Act of 2015

Issues related to TRICARE pharmacy benefit in HR4909 and S 2943 FY17 National Defense Authorization Act.

Issues related to National Diabetes Prevention Program in FY17 Labor/HHS/Education Appropriations, P.L. 114-113 FY16 Consolidated Appropriations, and P.L. 113-235 FY15 Consolidated and Continuing Appropriations; Issues related to Medicare Part D, FDA, patents, and federal procurement in S.Con.Res.11 FY16 Senate Budget Resolution and H.Con.Res.27 House Budget Resolution; H.R. 3660 and S.3126 Preventive Health Savings Act

Protecting Americans from Tax Hikes Act of 2015(PATH) provision of P.L. 114-113 FY16 Consolidated Appropriations; H.R. 880 R&D tax credit; corporate tax inversion generally and in amendments to S.Con.Res.11 FY16 Senate Budget Resolution and S. 1376 FY16 National Defense Authorization Act; interest deductibility IRC 163(j); Treasury proposed debt and equity regulations (Sec. 385)

Issues related to Medicare Part D, Special Diabetes Program, CHIP, and childhood obesity in P.L. 114-10 Medicare Access and CHIP Reauthorization Act of 2015 (MACRA); H.R. 2102 and S.1131 Medicare Diabetes Prevention Act; H.R. 2404 and S. 1509 Treat and Reduce Obesity Act; Issues related to medical nutrition therapy services to such beneficiaries with pre-diabetes or with risk factors for developing type 2 diabetes H.R. 1686 Medical Nutrition Therapy 2015; issues related to patient diabetes education in H.R. 1726 Access to Quality Diabetes Education Act of 2015; Continuous Glucose Monitoring (CGM); Medicare reimbursement of A1C for diabetes screening, and diabetes screening generally; H.R. 1021 Protecting the Integrity of Medicare Act (PIMA) of 2015; H.R.2005 and S. 1083 Medicare Drug Savings Act of 2015; Physician Quality and Reporting System (PQRS); CMMI Part B Demonstration

H.R. 9 Innovation Act and and S. 1137 PATENT Act (patent litigation and assertion); S.1890 and H.R.3326 Defend Trade Secrets Act of 2015

Issues related to Medicare Part D, Special Diabetes Program, CHIP, and childhood obesity in P.L. 114-10 Medicare Access and CHIP Reauthorization Act of 2015 (MACRA); H.R. 2102 and S.1131 Medicare Diabetes Prevention Act; H.R. 2404 and S. 1509 Treat and Reduce Obesity Act; Issues related to medical nutrition therapy services to such beneficiaries with pre-diabetes or with risk factors for developing type 2 diabetes H.R. 1686 Medical Nutrition Therapy 2015; issues related to patient diabetes education in H.R. 1726 Access to Quality Diabetes Education Act of 2015; Continuous Glucose Monitoring (CGM); Medicare diabetes screening generally; H.R. 1021 Protecting the Integrity of Medicare Act (PIMA) of 2015; H.R.2005 and S. 1083 Medicare Drug Savings Act of 2015; Physician Quality and Reporting System (PQRS); CMMI Part B Demonstration

National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), AHRQ and USPSTF diabetes screening standards; diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1192 and S. 586 National Diabetes Clinical Care Commission Act of 2015; P.L. 114-10, Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) for Special Diabetes Program, CHIP, and childhood obesity; S. 84 and H.R. 3658 Gestational Diabetes Act of 2015; H.R. 1190 and S. 141 Protecting Seniors' Access to Medicare Act of 2015 (IPAB repeal); H.R. 2651 Eliminating Disparities in Diabetes Prevention, Access, and Care Act of 2015 (EDDPAC); cost of diabetes generally; S. 320 and H.R. 744 Medical Innovation Act of 2015; S. 2023 and H.R. 3513 Prescription Drug Affordability Act of 2015; H.R. 3742, Access to Marketplace Insurance Act and general allowance for certain third party payments of cost sharing; Congressional recognition of World Hemophilia Day

P.L. 114-26 Bipartisan Congressional Trade Priorities and Accountability Act of 2015; EU/US Transatlantic Trade and Investment Partnership (TTIP) (intellectual property, regulatory harmonization)

H.R. 9 Innovation Act and and S. 1137 PATENT Act (patent litigation and assertion); S.1890 and H.R.3326 Defend Trade Secrets Act of 2015

Issues related to TRICARE pharmacy benefit in HR4909 and S 2943 FY17 National Defense Authorization Act.

P.L. 114-26 Bipartisan Congressional Trade Priorities and Accountability Act of 2015; EU/US Transatlantic Trade and Investment Partnership (TTIP) (intellectual property, regulatory harmonization)

Issues related to National Diabetes Prevention Program in FY17 Labor/HHS/Education Appropriations, P.L. 114-113 FY16 Consolidated Appropriations, and P.L. 113-235 FY15 Consolidated and Continuing Appropriations; Issues related to Medicare Part D, FDA, patents, and federal procurement in S.Con.Res.11 FY16 Senate Budget Resolution and H.Con.Res.27 House Budget Resolution; H.R. 3660 Preventive Health Savings Act

Issues related to TRICARE pharmacy benefit in FY17 National Defense Authorization Act.

P.L. 113-54 Drug Quality and Security Act (track and trace supply chain provisions); issues regarding biosimilars; issues regarding 340B; H.R.6 21st Century Cures Act; FDA in HR 3049 FY16 Agriculture Appropriations

Issues related to Medicare Part D, Special Diabetes Program, CHIP, and childhood obesity in P.L. 114-10 Medicare Access and CHIP Reauthorization Act of 2015 (MACRA); H.R. 2102 and S.1131 Medicare Diabetes Prevention Act; H.R. 2404 and S. 1509 Treat and Reduce Obesity Act; Issues related to medical nutrition therapy services to such beneficiaries with pre-diabetes or with risk factors for developing type 2 diabetes H.R. 1686 Medical Nutrition Therapy 2015; issues related to patient diabetes education in H.R. 1726 Access to Quality Diabetes Education Act of 2015; Continuous Glucose Monitoring (CGM); Medicare diabetes screening generally; H.R. 1021 Protecting the Integrity of Medicare Act (PIMA) of 2015; H.R.2005 and S. 1083 Medicare Drug Savings Act of 2015; Physician Quality and Reporting System (PQRS)

H.R. 9 Innovation Act and and S. 1137 PATENT Act (patent litigation and assertion); S.1890 and H.R.3326 Defend Trade Secrets Act of 2015

National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), AHRQ and USPSTF diabetes screening standards; diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1192 and S. 586 National Diabetes Clinical Care Commission Act of 2015; P.L. 114-10, Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) for Special Diabetes Program, CHIP, and childhood obesity; S. 84 and H.R. 3658 Gestational Diabetes Act of 2015; H.R. 1190 and S. 141 Protecting Seniors' Access to Medicare Act of 2015 (IPAB repeal); H.R. 2651 Eliminating Disparities in Diabetes Prevention, Access, and Care Act of 2015 (EDDPAC); cost of diabetes generally; S. 320 and H.R. 744 Medical Innovation Act of 2015; S. 2023 and H.R. 3513 Prescription Drug Affordability Act of 2015; H.R. 3742, Access to Marketplace Insurance Act and general allowance for certain third party payments of cost sharing; Congressional recognition of World Hemophilia Day

Issues related to TRICARE pharmacy benefit in FY17 National Defense Authorization Act.

Protecting Americans from Tax Hikes Act of 2015(PATH) provision of P.L. 114-113 FY16 Consolidated Appropriations; H.R. 880 R&D tax credit; corporate tax inversion generally and in amendments to S.Con.Res.11 FY16 Senate Budget Resolution and S. 1376 FY16 National Defense Authorization Act; interest deductibility IRC 163(j)

H.R. 9 Innovation Act and and S. 1137 PATENT Act (patent litigation and assertion); S.1890 and H.R.3326 Defend Trade Secrets Act of 2015

P.L. 114-26 Bipartisan Congressional Trade Priorities and Accountability Act of 2015; EU/US Transatlantic Trade and Investment Partnership (TTIP) (intellectual property, regulatory harmonization)

P.L. 113-54 Drug Quality and Security Act (track and trace supply chain provisions); issues regarding biosimilars; issues regarding 340B; H.R.6 21st Century Cures Act; FDA in HR 3049 FY16 Agriculture Appropriations

National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), AHRQ and USPSTF diabetes screening standards; diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1074 and S. 539 National Diabetes Clinical Care Commission Act of 2013; P.L. 114-10, Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) for Special Diabetes Program, CHIP, and childhood obesity; S. 84 and H.R. 3658 Gestational Diabetes Act of 2015; H.R. 1190 and S. 141 Protecting Seniors' Access to Medicare Act of 2015 (IPAB repeal); H.R. 2651 Eliminating Disparities in Diabetes Prevention, Access, and Care Act of 2015 (EDDPAC); cost of diabetes generally; S. 320 and H.R. 744 Medical Innovation Act of 2015; S. 2023 and H.R. 3513 Prescription Drug Affordability Act of 2015; H.R. 3742, Access to Marketplace Insurance Act and general allowance for certain third party payments of cost sharing.

Issues related to National Diabetes Prevention Program in H.R. 3020 and S.1695 FY16 Labor/HHS/Education Appropriations and P.L. 113-235 FY15 Consolidated and Continuing Appropriations; Issues related to Medicare Part D, FDA, patents, and federal procurement in S.Con.Res.11 FY16 Senate Budget Resolution and H.Con.Res.27 House Budget Resolution; H.R. 3660 Preventive Health Savings Act

H.R. 9 Innovation Act and and S. 1137 PATENT Act (patent litigation and assertion); S.1890 and H.R.3326 Defend Trade Secrets Act of 2015

P.L. 114-26 Bipartisan Congressional Trade Priorities and Accountability Act of 2015; EU/US Transatlantic Trade and Investment Partnership (TTIP) (intellectual property, regulatory harmonization)

Issues related to Medicare Part D, Special Diabetes Program, CHIP, and childhood obesity in P.L. 114-10 Medicare Access and CHIP Reauthorization Act of 2015 (MACRA); H.R. 2102 and S.1131 Medicare Diabetes Prevention Act; H.R. 2404 and S. 1509 Treat and Reduce Obesity Act; Issues related to medical nutrition therapy services to such beneficiaries with pre-diabetes or with risk factors for developing type 2 diabetes H.R. 1686 Medical Nutrition Therapy 2015; issues related to patient diabetes education in H.R. 1726 Access to Quality Diabetes Education Act of 2015; Continuous Glucose Monitoring (CGM); Medicare diabetes screening generally; H.R. 1021 Protecting the Integrity of Medicare Act (PIMA) of 2015; H.R.2005 and S. 1083 Medicare Drug Savings Act of 2015; Physician Quality and Reporting System (PQRS)

P.L. 114-26 Bipartisan Congressional Trade Priorities and Accountability Act of 2015; EU/US Transatlantic Trade and Investment Partnership (TTIP) (intellectual property, regulatory harmonization)

Issues related to National Diabetes Prevention Program in H.R. 3020 and S.1695 FY16 Labor/HHS/Education Appropriations, P.L. 114-113 FY16 Consolidated Appropriations, and P.L. 113-235 FY15 Consolidated and Continuing Appropriations; Issues related to Medicare Part D, FDA, patents, and federal procurement in S.Con.Res.11 FY16 Senate Budget Resolution and H.Con.Res.27 House Budget Resolution; H.R. 3660 Preventive Health Savings Act

National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), AHRQ and USPSTF diabetes screening standards; diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1192 and S. 586 National Diabetes Clinical Care Commission Act of 2015; P.L. 114-10, Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) for Special Diabetes Program, CHIP, and childhood obesity; S. 84 and H.R. 3658 Gestational Diabetes Act of 2015; H.R. 1190 and S. 141 Protecting Seniors' Access to Medicare Act of 2015 (IPAB repeal); H.R. 2651 Eliminating Disparities in Diabetes Prevention, Access, and Care Act of 2015 (EDDPAC); cost of diabetes generally; S. 320 and H.R. 744 Medical Innovation Act of 2015; S. 2023 and H.R. 3513 Prescription Drug Affordability Act of 2015; H.R. 3742, Access to Marketplace Insurance Act and general allowance for certain third party payments of cost sharing.

Health, Medicare, Tax, Trade, and Intellectual Property

Health, Medicare, Tax, Trade, and Intellectual Property

P.L. 114-26 Bipartisan Congressional Trade Priorities and Accountability Act of 2015; EU/US Transatlantic Trade and Investment Partnership (TTIP) (intellectual property, regulatory harmonization)

National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), AHRQ and USPSTF diabetes screening standards; diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1074 and S. 539 National Diabetes Clinical Care Commission Act of 2013; P.L. 114-10, Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) for Special Diabetes Program, CHIP, and childhood obesity; S. 84 and H.R. 3658 Gestational Diabetes Act of 2015; H.R. 1190 and S. 141 Protecting Seniors' Access to Medicare Act of 2015 (IPAB repeal); H.R. 2651 Eliminating Disparities in Diabetes Prevention, Access, and Care Act of 2015 (EDDPAC); cost of diabetes generally; S. 320 and H.R. 744 Medical Innovation Act of 2015; S. 2023 and H.R. 3513 Prescription Drug Affordability Act of 2015; H.R. 3742, Access to Marketplace Insurance Act and general allowance for certain third party payments of cost sharing.

H.R. 9 Innovation Act and and S. 1137 PATENT Act (patent litigation and assertion); S.1890 and H.R.3326 Defend Trade Secrets Act of 2015

P.L. 113-54 Drug Quality and Security Act (track and trace supply chain provisions); issues regarding biosimilars; issues regarding 340B; H.R.6 21st Century Cures Act; FDA in HR 3049 FY16 Agriculture Appropriations

Issues related to National Diabetes Prevention Program in H.R. 3020 and S.1695 FY16 Labor/HHS/Education Appropriations and P.L. 113-235 FY15 Consolidated and Continuing Appropriations; Issues related to Medicare Part D, FDA, patents, and federal procurement in S.Con.Res.11 FY16 Senate Budget Resolution and H.Con.Res.27 House Budget Resolution; H.R. 3660 Preventive Health Savings Act

Issues related to Medicare Part D, Special Diabetes Program, CHIP, and childhood obesity in H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015 (MACRA); H.R. 2102 / S.1131 Medicare Diabetes Prevention Act; H.R. 2404 and S. 1509 Treat and Reduce Obesity Act; Issues related to medical nutrition therapy services to such beneficiaries with pre-diabetes or with risk factors for developing type 2 diabetes H.R. 1686 Medical Nutrition Therapy 2015; issues related to patient diabetes education in H.R. 1726 Access to Quality Diabetes Education Act of 2015; Continuous Glucose Monitoring (CGM); Medicare diabetes screening generally; H.R. 1021 Protecting the Integrity of Medicare Act (PIMA) of 2015; H.R.2005 and S. 1083 Medicare Drug Savings Act of 2015; Physician Quality and Reporting System (PQRS)

P.L. 114-26 Bipartisan Congressional Trade Priorities and Accountability Act of 2015; EU/US Transatlantic Trade and Investment Partnership (TTIP) (intellectual property, regulatory harmonization)

National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), AHRQ and USPSTF diabetes screening standards; diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1074 and S. 539 National Diabetes Clinical Care Commission Act of 2013; H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) for Special Diabetes Program, CHIP, and childhood obesity; S. 84 Gestational Diabetes Act of 2015; H.R. 1190 and S. 141 Protecting Seniors' Access to Medicare Act of 2015 (IPAB repeal); H.R. 2651 Eliminating Disparities in Diabetes Prevention, Access, and Care Act of 2015 (EDDPAC); cost of diabetes generally; S. 320 and H.R. Medical Innovation Act of 2015

H.R. 9 Innovation Act and and S. 1137 PATENT Act (patent litigation and assertion)

National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), AHRQ and USPSTF diabetes screening standards;diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1074 and S. 539 National Diabetes Clinical Care Commission Act of 2013; H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) for Special Diabetes Program, CHIP, and childhood obesity; S. 84 Gestational Diabetes Act of 2015; H.R. 1190 and S. 141 Protecting Seniors' Access to Medicare Act of 2015 (IPAB repeal); cost of diabetes

H.R. 9 Innovation Act (patent litigation and assertion)

P.L. 113-54 Drug Quality and Security Act (track and trace supply chain provisions); issues regarding biosimilars; issues regarding 340B

R&D tax credit generally; corporate tax inversion generally

HR 3204, S. 959 Drug Quality and Security Act (track and trace supply chain provisions); issues regarding biosimilars; 340B

H.R. 3309 Innovation Act and S. 1720 Patent Transparency and Improvements Act of 2013 (patent litigation and assertion); demand letters

Issues related to insulin pen safety and access in the VA

R&D Tax Credit;H.R. 2052; S. 1023 Global Investment in American Jobs Act of 2013; corporate tax inversion; P.L.113-295 Tax Increase Prevention Act of 2014

H.R. 962 and S. 452 Medicare Diabetes Prevention Act of 2013; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011 and H.R. 8 American Taxpayer Relief Actof 2012; H.R. 1588 & S. 740 Medicare Drug Savings Act of 2013; H.R. 1257 Preventing Diabetes in Medicare Act of 2013 and prediabetes generally; H.R. 1274 and S 945 Access to Quality Diabetes Education Act of 2013 (Diabetes Self-Management Training in Medicare);Medicare diabetes screening generally; S. 1184 and H.R. 2415 Treat and Reduce Obesity Act of 2013 and obesity medication coverage generally; Diabesity amendment to S. 1871 SGR Repeal and Medicare Beneficiary Access; Physician Quality and Reporting System (PQRS)

Issues related to Medicare Part D, FDA and patents in S. Con. Res. 8; FY14 Omnibus; H. Con Res. 25 House Budget Resolution; H.R. 2663 and S. 1422 The Preventative Health Savings Act of 2013 (Modernizing CBO scoring with respect to preventive health legislation); National Diabetes Prevention Program; HR 933 -- Consolidated and Further Continuing Appropriations Act, 2013; FY15 Labor/HHS/Education Appropriations (National Diabetes Prevention Program);H.J. Res. 59 FY14 Continuing Appropriations Resolution (contains Bipartisan Budget Act of 2013). H Con Res 96 the House FY 2015 Budget; H.J.Res 124 Continuing Appropriations Resolution FY15; P.L. 113-235 FY15 Consolidated and Continuing Appropriations

EU/US Transatlantic Trade and Investment Partnership (TTIP) (intellectual property)

Issues related to Medicare Part D, FDA and patents in S. Con. Res. 8; FY14 Omnibus; H. Con Res. 25 House Budget Resolution; H.R. 2663 and S. 1422 The Preventative Health Savings Act of 2013 (Modernizing CBO scoring with respect to preventive health legislation); National Diabetes Prevention Program; HR 933 -- Consolidated and Further Continuing Appropriations Act, 2013; FY15 Labor/HHS/Education Appropriations (National Diabetes Prevention Program);H.J. Res. 59 FY14 Continuing Appropriations Resolution (contains Bipartisan Budget Act of 2013). H Con Res 96 the House FY 2015 Budget; H.J.Res 124 Continuing Appropriations Resolution FY15

H.R. 962 and S. 452 Medicare Diabetes Prevention Act of 2013; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011 and H.R. 8 American Taxpayer Relief Actof 2012; H.R. 1588 & S. 740 Medicare Drug Savings Act of 2013; H.R. 1257 Preventing Diabetes in Medicare Act of 2013 and prediabetes generally; H.R. 1274 and S 945 Access to Quality Diabetes Education Act of 2013 (Diabetes Self-Management Training in Medicare);Medicare diabetes screening generally; S. 1184 and H.R. 2415 Treat and Reduce Obesity Act of 2013 and obesity medication coverage generally; Diabesity amendment to S. 1871 SGR Repeal and Medicare Beneficiary Access; Physician Quality and Reporting System (PQRS)

R&D Tax Credit;H.R. 2052; S. 1023 Global Investment in American Jobs Act of 2013; corporate tax inversion

H.R. 3309 Innovation Act and S. 1720 Patent Transparency and Improvements Act of 2013 (patent litigation and assertion); demand letters

Issues related to insulin pen safety and access in the VA

National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), AHRQ and USPSTF diabetes screening standards;diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1074 and S. 539 National Diabetes Clinical Care Commission Act of 2013; S.RES.242 and H.RES.313 Supporting the goals and ideals of "Growth Awareness Week" and the MAGIC Foundation; H.R. 4302, Protecting Access to Medicare Act; S. 2157, Commonsense Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014 (Special Diabetes Program reauthorization); H.R. 1915 and S. 907 Gestational Diabetes Act of 2013; H.R. 3322, Eliminating Disparities in Diabetes Prevention, Access, and Care Act of 2013; H.R. 351 and S. 351 Protecting Seniors' Access to Medicare Act of 2013 (IPAB repeal)

EU/US Transatlantic Trade and Investment Partnership (TTIP) (intellectual property)

H.R. 962 and S. 452 Medicare Diabetes Prevention Act of 2013; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011 and H.R. 8 American Taxpayer Relief Actof 2012; H.R. 1588 & S. 740 Medicare Drug Savings Act of 2013; H.R. 1257 Preventing Diabetes in Medicare Act of 2013 and prediabetes generally; H.R. 1274 and S 945 Access to Quality Diabetes Education Act of 2013 (Diabetes Self-Management Training in Medicare);Medicare diabetes screening generally; S. 1184 and H.R. 2415 Treat and Reduce Obesity Act of 2013; Diabesity amendment to S. 1871 SGR Repeal and Medicare Beneficiary Access; Physician Quality and Reporting System (PQRS)

H.R. 3309 Innovation Act and S. 1720 Patent Transparency and Improvements Act of 2013 (patent litigation and assertion); demand letters

Issues related to insulin pen safety and access in the VA

National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), Prevention and Public Health Fund, AHRQ and USPSTF diabetes screening standards;diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1074 and S. 539 National Diabetes Clinical Care Commission Act of 2013; S.RES.242 and H.RES.313 Supporting the goals and ideals of "Growth Awareness Week" and the MAGIC Foundation; H.R. 4302, Protecting Access to Medicare Act; S. 2157, Commonsense Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014 (Special Diabetes Program reauthorization); H.R. 1915 and S. 907 Gestational Diabetes Act of 2013; H.R. 3322, Eliminating Disparities in Diabetes Prevention, Access, and Care Act of 2013; H.R. 351 and S. 351 Protecting Seniors' Access to Medicare Act of 2013 (IPAB repeal)

Issues related to insulin pen safety and access in the VA

H.R. 962 and S. 452 Medicare Diabetes Prevention Act of 2013; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011 and H.R. 8 American Taxpayer Relief Actof 2012; H.R. 1588 & S. 740 Medicare Drug Savings Act of 2013; H.R. 1257 Preventing Diabetes in Medicare Act of 2013 and prediabetes generally; H.R. 1274 and S 945 Access to Quality Diabetes Education Act of 2013 (Diabetes Self-Management Training in Medicare);Medicare diabetes screening generally; S. 1184 and H.R. 2415 Treat and Reduce Obesity Act of 2013; Diabesity amendment to S. 1871 SGR Repeal and Medicare Beneficiary Access; Physician Quality and Reporting System (PQRS)

EU/US Transatlantic Trade and Investment Partnership (TTIP) (intellectual property)

HR 3204, S. 959 Drug Quality and Security Act (track and trace supply chain provisions); issues regarding biosimilars; 340B

EU/US Transatlantic Trade and Investment Partnership (TTIP) (intellectual property); Trans-Pacific Partnership (TPP) (intellectual property)

Issues related to insulin pen safety and access in the VA

H.R. 962 and S. 452 Medicare Diabetes Prevention Act of 2013; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011, H.R. 8 American Taxpayer Relief Act of 2012, and H.R. 1588 and S. 740 Medicare Drug Savings Act of 2013; H.R. 1257 Preventing Diabetes in Medicare Act of 2013 and prediabetes generally; H.R. 1274 and S. 945 Access to Quality Diabetes Education Act of 2013 (Diabetes Self-Management Training in Medicare);Medicare diabetes screening generally; S. 1184 and H.R. 2415 Treat and Reduce Obesity Act of 2013; Diabesity amendment to S. 1871 SGR Repeal and Medicare Beneficiary Access; Physician Quality and Reporting System (PQRS)

H.R. 3309 Innovation Act and S. 1720 Patent Transparency and Improvements Act of 2013 (patent litigation and patent assertion)

Issues related to Medicare Part D, FDA & patents in S. Con. Res. 8 FY14 Senate Budget Resolution; H. Con. Res. 25 House Budget Resolution; H.R. 2663 & S. 1422 The Preventative Health Savings Act of 2013 (Modernizing CBO scoring estimates with respect to preventive health legislation); National Diabetes Prevention Program in H.R. 933 FY13 Consolidated and Further Continuing Appropriations Act & S. 1284 FY14 Depts. of Labor, Health and Human Services, and Education Appropriations ActH.J. Res 59 FY14 Continuing Appropriations Resolution (contains Bipartisan Budget Act of 2013) and issues related to the continuing resolution and debt ceiling.

P.L. 113-054 Drug Quality and Security Act, H.R.1919 Safeguarding America's Pharmaceuticals Act of 2013 and S.959 Pharmaceutical Compounding Quality and Accountability Act (for track and trace supply chain provisions); issues regarding biosimilars; 340B

Issues related to patent litigation and patent assertion

National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), Prevention and Public Health Fund, AHRQ and USPSTF diabetes screening standards;diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1074 and S. 539 National Diabetes Clinical Care Commission Act of 2013; S.RES.242 and H.RES.313 Supporting the goals and ideals of "Growth Awareness Week" and the MAGIC Foundation; H.R. 8 American Taxpayer Relief Act (Special Diabetes Program reauthorization); H.R. 1915 and S. 907 Gestational Diabetes Act of 2013; diabetes disparities; H.R. 351 and S. 351 Protecting Seniors' Access to Medicare Act of 2013 (IPAB repeal)

H.R. 8 American Taxpayer Relief Act (R&D tax credit) of 2012 (R&D credit); H.R. 2052 and S. 1023 Global Investment in American Jobs Act

H.R. 962 and S. 452 Medicare Diabetes Prevention Act of 2013; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011, H.R. 8 American Taxpayer Relief Act of 2012, and H.R. 1588 and S. 740 Medicare Drug Savings Act of 2013; H.R. 1257 Preventing Diabetes in Medicare Act of 2013 and prediabetes generally; H.R. 1274 and S. 945 Access to Quality Diabetes Education Act of 2013 (Diabetes Self-Management Training in Medicare);Medicare diabetes screening generally; S. 1184 and H.R. 2415 Treat and Reduce Obesity Act of 2013; Physician Quality and Reporting System (PQRS)

EU/US Transatlantic Trade and Investment Partnership (TTIP) (intellectual property); Trans-Pacific Partnership (TPP) (intellectual property)

Issues related to insulin pen safety and access in the VA

Issues related to patent litigation and patent assertion entities (PAEs) aka patent trolls

Issues related to Medicare Part D, FDA and patents in S. Con. Res. 8 FY14 Senate Budget Resolution; H. Con. Res. 25 House Budget Resolution; H.R. 2663 The Preventative Health Savings Act of 2013 (Modernizing CBO scoring estimates with respect to preventive health legislation); National Diabetes Prevention Program in H.R. 933 -- FY13 Consolidated and Further Continuing Appropriations Act and S. 1284 FY14 Depts. of Labor, Health and Human Services, and Education Appropriations Act

National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), Prevention and Public Health Fund, AHRQ and USPSTF diabetes screening standards;diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1074 and S. 539 National Diabetes Clinical Care Commission Act of 2013; human growth / rare disorders awareness; H.R. 8 American Taxpayer Relief Act (Special Diabetes Program reauthorization); gestational diabetes; diabetes disparities; H.R. 351 and S. 351 Protecting Seniors' Access to Medicare Act of 2013 (IPAB repeal)

EU/US Transatlantic Trade and Investment Partnership (TTIP) (intellectual property); Trans-Pacific Partnership (TPP) (intellectual property)

National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), Prevention and Public Health Fund, AHRQ and USPSTF diabetes screening standards;diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1074 and S 539 National Diabetes Clinical Care Commission Act of 2013; human growth / rare disorders awareness; H.R. 8 American Taxpayer Relief Act (Special Diabetes Program reauthorization); gestational diabetes; diabetes disparities; H.R. 351 and S. 351 Protecting Seniors' Access to Medicare Act of 2013 (IPAB repeal)

Issues regarding Pharmaceutical Traceability Enhancement Code (Rx TEC) Act and discussion draft on serialization (track and trace); S.622 -- Animal Drug and Animal Generic Drug User Fee Reauthorization Act of 2013 for amendments that would impact human drug user fees; issues regarding biosimilars; 340B

EU/US Transatlantic Trade and Investment Partnership (TTIP) (intellectual property); Trans-Pacific Partnership (TPP); intellectual property

P.L. 112-186, SAFE DOSES Act (Modernizing criminal laws concerning theft of medical products)

HR 6621 Technical corrections to the America Invents Act; S. 3486, the Patent Law Treaties Implementation Act of 2012

S. 3295 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2013 (National Diabetes Prevention Program); HR 6482 The Preventative Health Savings Act of 2012 (modernizing cost estimates with respect to CBO scoring of preventive health legislation); and National Diabetes Prevention Program

P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity; Medicare Diabetes Screening; HR 6548 Medicare Diabetes Prevention Act of 2012; S 3463 Medicare Diabetes Prevention Act of 2012; HR 2741, Preventing Diabetes in Medicare Act of 2011 and Prediabetes generally; Medicaid coverage of obesity counseling and expanding provider type; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011 (deficit reduction) and HR 8 American Taxpayer Relief Act of 2012

Trans-Pacific Partnership (TPP): biosimilar provisions

S. 3295 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2013 (National Diabetes Prevention Program); HR 6482 The Preventative Health Savings Act of 2012 (modernizing cost estimates with respect to CBO scoring of preventive health legislation); and National Diabetes Prevention Program

P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity; Medicare Diabetes Screening; HR 6548 Medicare Diabetes Prevention Act of 2012; S 3463 Medicare Diabetes Prevention Act of 2012; HR 2741, Preventing Diabetes in Medicare Act of 2011 and Prediabetes generally; Medicaid coverage of obesity counseling and expanding provider type; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011 (deficit reduction)

Trans-Pacific Partnership (TPP): biosimilar provisions

S. 1002 SAFE DOSES Act and HR 4223 Safe Doses Act (Modernizing criminal laws concerning theft of medical products)

P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity; Medicare Diabetes Screening; HR 2741, Preventing Diabetes in Medicare Act of 2011 and Prediabetes generally; Medicaid coverage of obesity counseling and expanding provider type; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011 (deficit reduction)

H.R. 436 Protect Medical Innovation Act of 2011

P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample reporting provisions; S.3187 FDA Safety and Innovation Act (PDUFA V); H.R. 4274 Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; Pharmaceutical Traceability Enhancement Code (Rx TEC) Act; H.R. 5973 FY2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (FDA funding); 340B

FY12 Budget Resolution and FY13 Appropriations: diabetes-related issues and issues related to modernizing cost estimates with respect to preventive health legislation and National Diabetes Prevention Program HR 2608 (PL 112-36) Continuing Appropriations Act, 2012; HJ RES 94 (PL 112-67); CR through 12/17/11; HJ RES 95 (PL 112-68) CR through 12/23/11; P.L. 112-74 Consolidated Appropriations Act of 2012 on National Diabetes Prevention Program

H.R. 436 Protect Medical Innovation Act of 2011

S. 1002 SAFE DOSES Act and HR 4223 Safe Doses Act (Modernizing criminal laws concerning theft of medical products)

P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity; Medicare Diabetes Screening; HR 2741, Preventing Diabetes in Medicare Act of 2011 and Prediabetes generally; Issues related to Medicaid rebates and similar revenue provisions as contained in P.L. 112-25, Budget Control Act of 2011 (deficit reduction); HR 3743 Middle Class Tax Relief and Job Creation Act of 2011, HR 3630 Middle Class Tax Relief and Job Creation Act of 2011, and HR 3765 (PL 112-78) Temporary Payroll Tax Cut Continuation of 2011-Issues related to Medicaid rebates and similar revenue provisions; Medicaid coverage of obesity counseling and expanding provider type.

P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample reporting provisions; HR 2112 FY12 Agriculture, Commerce/State/Justice, Transportation, & HUD Appropriations on prescription drug reimportation; Prescription Drug User Fee Act reauthorization Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; Supply Chain safety; Pharmaceutical Traceability Enhancement Code (Rx TEC) Act

FY12 Budget Resolution: diabetes-related issues and issues related to modernizing cost estimates with respect to preventive health legislation; HR 2608 (PL 112-36) Continuing Appropriations Act, 2012; HJ RES 94 (PL 112-67); CR through 12/17/11; HJ RES 95 (PL 112-68) CR through 12/23/11; P.L. 112-74 Consolidated Appropriations Act of 2012 on National Diabetes Prevention Program

Supporting increasing funding opportunities for better care and treatment of people with diabetes in P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically minority health, diabetes screening, National Diabetes Prevention Program, National Prevention Strategy, Medicaid Quality Measures, Medicare Annual Wellness Visit, ACOs (related to Medicare Share Savings Program), Coverage of Preventive Services under ACA, HHS Strategic Plan, HHS Multiple Chronic Conditions Framework, National Quality Strategy, Prevention and Public Health Fund, Diabetes Prevention Issues in a Survey of Primary Care Physicians, Adequate Inclusion of Diabetes Care In the Essential Health Benefits Package, IOM Committee on Valuing Community-based Non-Clinical Prevention Policies and Wellness Strategies, DOL Survey of Employer-Sponsored Health Insurance Coverage, CDC National Survey of Primary Care Policies for Managing Patients with Higher Blood Pressure, High Cholesterol, or Diabetes (NSPCP); H.R. 2954, the Health Equity and Accountability Act of 2011; HR 2960 National Diabetes Clinical Care Commission Act; S. 1559 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2012 on National Diabetes Prevention Program; CMS Obesity Intervention; Healthy People 2020 Abstract; CMS CLIA Program & HIPAA Privacy Rule Patient Access to Test Reports; AHRQ regarding the USPSTF recommendation on screening and management of obesity in adults

H.R. 436 Protect Medical Innovation Act of 2011

S. 1002 SAFE DOSES Act (Modernizing criminal laws concerning theft of medical products)

H.R. 436 Protect Medical Innovation Act of 2011

Supporting increasing funding opportunities for better care and treatment of people with diabetes in P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically minority health, diabetes screening, National Diabetes Prevention Program, National Prevention Strategy, Medicaid Quality Measures, Medicare Annual Wellness Visit, ACOs (related to Medicare Share Savings Program), Coverage of Preventive Services under ACA, HHS Strategic Plan, HHS Multiple Chronic Conditions Framework, National Quality Strategy, Prevention and Public Health Fund, Diabetes Prevention Issues in a Survey of Primary Care Physicians, Adequate Inclusion of Diabetes Care In the Essential Health Benefits Package, IOM Committee on Valuing Community-based Non-Clinical Prevention Policies and Wellness Strategies, DOL Survey of Employer-Sponsored Health Insurance Coverage, CDC National Survey of Primary Care Policies for Managing Patients with Higher Blood Pressure, High Cholesterol, or Diabetes (NSPCP); H.R. 2954, the Health Equity and Accountability Act of 2011; HR 2960 National Diabetes Clinical Care Commission Act; S. 1559 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2012

H.R. 1249 and S. 23, America Invents Act

S. 1002 SAFE DOSES Act (Modernizing criminal laws concerning theft of medical products)

H.R. 1249 and S. 23, America Invents Act

P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample transparency reporting provisions; prescription drug reimportation generally; Prescription Drug User Fee Act reauthorization

H.R. 436 Protect Medical Innovation Act of 2011

S. 1002 SAFE DOSES Act (Modernizing criminal laws concerning theft of medical products)

P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; Deficit reduction and debt ceiling negotiations: Issues related to Medicare Parts B & D, Medicaid rebates and the 340B program.

H.R. 1, Full Year Continuing Appropriations FY11; H.J. Res. 44, Further Continuing Appropriations FY11; H.J. Res. 48, Further Continuing Appropriations FY11; FY12 Budget Resolution: diabetes-related issues and issues related to modernizing cost estimates with respect to preventive health legislation

P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA); P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, Prescription Drug User Fee Act reauthorization, prescription drug reimportation generally, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample transparency reporting provisions

Issues related to Medicaid rebates and similar revenue provisions as contained in P.L. 111-148, Patient Protection and Affordable Care Act of 2009; P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; H.R. 4213, American Jobs and Closing Tax Loopholes Act of 2010, and S. 3793, Jobs Creation and Tax Cut Act; and H.R. 3081, Continuing Appropriations Act 2011, issues related to the 340(b) program

H.R. 3148, the Preventive Health Savings Act; H.R. 3663 and S. 3058, To amend the Public Health Service Act to reauthorize the special diabetes programs for Type I diabetes and Indians under that Act; S. 3686 Labor, Health and Human Services, and Education Appropriations Act, 2011, diabetes-related provisions

H.R. 5175 and S. 3628, Democracy is Strengthened by Casting Light on Spending in Elections (DISCLOSE) Act

H.R. 4853 (P.L. 111-312) Tax Relief, Unemployment Insurance Reauthorization, and Job Creation Act of 2010

Supporting increasing funding opportunities for better care and treatment of people with diabetes in P.L. 111-148, Patient Protection and Affordable Care Act of 2009; P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010, including National Diabetes Prevetion Program, National Quality Strategy, and Public Health Fund

H.R. 1260 and S. 515, Patent Reform Act of 2009, entire bill; H.R. 1408, Sunshine in Litigation Act

Protecting patient safety in H.R. 1427 and S. 726, Promoting Innovation and Access to Life-Savings Medicine Act; H.R. 1548, Pathway for Biosimilars Act; H.R. 3200, and S. ?, Affordable Health Choices Act, biosimilar provisions

H.R. 3148, the Preventive Health Savings Act

H.R. 759, FDA Globalization Act; S. 301, Physician Payments Sunshine Act of 2009, issues related to federal preemption; H.R. 2502, Comparative Effectiveness Research Act of 2009; S. 1213, Patient-Centered Outcomes Research Act of 2009

H.R. 1260 and S. 515, Patent Reform Act of 2009, entire bill

H.R. 759, FDA Globalization Act; S. 301, Physician Payments Sunshine Act of 2009; issues related to federal preemption

H.R. 1260 and S. 515, Patent Reform Act of 2009, entire bill; S. 515 Patent Reform Act; H.R. 1408, Sunshine in Litigation Act

H.R. 759, FDA Globalization Act; S. 301, Physician Payments Sunshine Act of 2009; issues related to federal preemption

S.3123, Closing the Foreign Lobbying Loophole Act; H.R. 4854, False Claims Corrections Act of 2007

H.R. 2638 and S. 1644, Homeland Security Appropriations Act, drug importation provisions; H.R. 3043 and S. 1710, Labor-HHS-Education and Related Agencies Appropriations Act, drug importation and diabetes provisions; H.R. 3161 and S. 1859, Agriculture, Rural Development, Food and Drug Administration Appropriations Act, drug importation provisions; H.R. 3093 and S. 1745, Commerce, Justice, Science and Related Agencies Appropriations Act, drug importation provisions.

H.R. 3610, Foreign Facility FDA Inspection User Fees; H.R. 1585, National Defense Authorization (portions relating to Tricare); protecting patient access in S. 877, Controlling the Abuse of Prescriptions Act; S. 2029, Physician Payments Sunshine Act of 2007; S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion

Issues related to taxation, including extension of the R&D tax credit as contained in H.R. 1424, The Emergency Economic Stabilization Act of 2008

S.3123, Closing the Foreign Lobbying Loophole Act; H.R. 4854, False Claims Corrections Act of 2007

H.R. 2638 and S. 1644, Homeland Security Appropriations Act, drug importation provisions; H.R. 3043 and S. 1710, Labor-HHS-Education and Related Agencies Appropriations Act, drug importation and diabetes provisions; H.R. 3161 and S. 1859, Agriculture, Rural Development, Food and Drug Administration Appropriations Act, drug importation provisions; H.R. 3093 and S. 1745, Commerce, Justice, Science and Related Agencies Appropriations Act, drug importation provisions.

Improve the care and treatment of people with diabetes in H.R. 4836 and S. 2742, the National Diabetes Coordinator Act; H.R. 3544 and S. 2479, Catalyst for Better Diabetes Care Act; H.R. 2922 and S. 1302 (partial), the Preventing Diabetes in Medicare Act; H.R. 2762 and H.R. 1494, Reauthorize Special Diabetes Programs

H.R. 3610, Foreign Facility FDA Inspection User Fees; H.R. 1585, National Defense Authorization (portions relating to Tricare); protecting patient access in S. 877, Controlling the Abuse of Prescriptions Act; S. 2029, Physician Payments Sunshine Act of 2007; S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion

H.R. 2638 and S. 1644, Homeland Security Appropriations Act, drug importation provisions; H.R. 3043 and S. 1710, Labor-HHS-Education and Related Agencies Appropriations Act, drug importation and diabetes provisions; H.R. 3161 and S. 1859, Agriculture, Rural Development, Food and Drug Administration Appropriations Act, drug importation provisions; H.R. 3093 and S. 1745, Commerce, Justice, Science and Related Agencies Appropriations Act, drug importation provisions.

H.R. 1908 and S. 1145, Patent Reform Act of 2007 (entire bill)

H.R. 3162, Children's Health and Medicare Protection Act of 2007; S. 2499, Medicare, Medicaid, and SCHIP Extension Act of 2007; H.R. 4/S. 3, Medicare Prescription Drug Price Negotiation Act; H.R. 2058, Helping Fill the Medicare Rx Gap Act of 2007; issues relating to comparative effectiveness

H.R. 3610, Foreign Facility FDA Inspection User Fees; H.R. 1585, National Defense Authorization (portions relating to Tricare); protecting patient access in S. 877, Controlling the Abuse of Prescriptions Act; S. 2029, Physician Payments Sunshine Act of 2007; S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion

H.R. 3162, Children's Health and Medicare Protection Act of 2007; S. 2499, Medicare, Medicaid, and SCHIP Extension Act of 2007; H.R. 4/S. 3, Medicare Prescription Drug Price Negotiation Act; H.R. 2058, Helping Fill the Medicare Rx Gap Act of 2007; issues relating to comparative effectiveness

H.R. 4 and S. 3, Medicare Prescription Drug Price Negotiation Act; S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007; H.R. 1561, Enhancing Drug Safety and Innovation Act of 2007; H.R. 3580, Food and Drug Administration Amendments Act of 2007; S. 1082, Prescription Drug User Fee Amendments of 2007; H.R. 2058, Helping Fill the Medicare Rx Gap Act of 2007

H.R. 2638 and S. 1644, Homeland Security Appropriations Act, drug importation provisions; H.R. 3043 and S. 1710, Labor-HHS-Education and Related Agencies Appropriations Act, drug importation and diabetes provisions; H.R. 3161 and S. 1859, Agriculture, Rural Development, Food and Drug Administration Appropriations Act, drug importation provisions; H.R. 3093 and S. 1745, Commerce, Justice, Science and Related Agencies Appropriations Act; drug importation provisions.

* S. 755, Diabetes Screening and Medicaid Savings Act H.R. 2762, S 1494, Reauthorization of Special Diabetes Funding for Type 1 Diabetes and Indians S. 631, Remote Patient Management for Diabetes and Other Chronic Health Care Conditions H.R. 1224, Physical Education Content and Performance Standards in Schools H.R. 2210, Diabetes Prevention Access and Care Act H.R. 2922, Preventing Diabetes in Medicare Act S. 1161, HELP America bill, pre-diabetes medicare provisions H.R. 2241, S. 1391, Diabetes Treatment and Prevention Act S. 242, H.R. 380 Pharmaceutical Market Access and Drug Safety Act of 2007 H.R. 1038, S. 623, Access to Life-Saving Medicine Act, follow-on biologics H.R. 1956, Patient Protection and innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics 5 6

S. 1145, H.R. 1908, Patent Reform Act; PTO continuation practice reforms